MECHI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 2.396
EU - Europa 1.816
AS - Asia 1.201
SA - Sud America 126
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 46
OC - Oceania 12
Totale 5.664
Nazione #
US - Stati Uniti d'America 2.350
RU - Federazione Russa 607
IT - Italia 566
SG - Singapore 286
HK - Hong Kong 272
CN - Cina 262
PL - Polonia 183
IE - Irlanda 123
BR - Brasile 99
VN - Vietnam 99
KR - Corea 75
SE - Svezia 75
FR - Francia 62
DE - Germania 51
JO - Giordania 51
IN - India 50
FI - Finlandia 41
GB - Regno Unito 35
NL - Olanda 31
CA - Canada 27
JP - Giappone 25
SA - Arabia Saudita 17
MA - Marocco 14
BD - Bangladesh 12
AU - Australia 11
MX - Messico 11
CI - Costa d'Avorio 10
EC - Ecuador 9
ID - Indonesia 9
UA - Ucraina 9
AR - Argentina 8
ZA - Sudafrica 8
NG - Nigeria 7
TR - Turchia 7
BE - Belgio 6
CH - Svizzera 6
IQ - Iraq 6
IR - Iran 5
PH - Filippine 5
ES - Italia 4
CO - Colombia 3
GR - Grecia 3
HU - Ungheria 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
IL - Israele 2
KE - Kenya 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BJ - Benin 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
MQ - Martinica 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.597
Città #
Santa Clara 517
Ashburn 334
Hong Kong 246
Singapore 205
Warsaw 180
San Jose 157
Chandler 132
Dublin 123
Fairfield 120
Milan 111
Beijing 87
Seoul 75
Seattle 57
Council Bluffs 51
Rome 51
Houston 49
Woodbridge 46
Ann Arbor 43
Cambridge 41
Los Angeles 41
Hefei 40
Ho Chi Minh City 38
Wilmington 37
Florence 35
Lawrence 35
Buffalo 34
Altamura 32
New York 32
Mumbai 27
Princeton 27
The Dalles 26
Kent 25
Lauterbourg 25
Tokyo 25
Munich 23
Shanghai 22
Boston 21
Turku 21
Hanoi 19
Moscow 19
Clifton 18
Paris 18
Naples 15
São Paulo 15
Riyadh 14
Modena 13
Turin 13
Casablanca 12
Helsinki 12
Frankfurt am Main 11
Abidjan 10
Chicago 10
Dallas 10
Dearborn 10
San Diego 10
Trieste 10
Catania 9
London 9
Melbourne 9
Chennai 8
Da Nang 8
Genoa 8
Jacksonville 8
Orem 8
Toronto 8
Abuja 7
Jakarta 7
Medford 7
Norwalk 7
Palermo 7
Stockholm 7
Bern 6
Boardman 6
Brussels 6
Nuoro 6
West Jordan 6
Atlanta 5
Guangzhou 5
Johannesburg 5
Lappeenranta 5
Manchester 5
Porto Alegre 5
Quito 5
Rio de Janeiro 5
Verona 5
Belo Horizonte 4
Bologna 4
Denver 4
Forlì 4
Hải Dương 4
Poplar 4
Querétaro 4
Amman 3
Amsterdam 3
Baghdad 3
Bitonto 3
Brooklyn 3
Columbus 3
Elk Grove Village 3
Montreal 3
Totale 3.674
Nome #
K index improves MS diagnosis and supports the differential diagnosis between MS and MS-like syndromes. 460
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 338
Suicidal ideation in a European Huntington's disease population 294
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 244
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 232
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis 219
Clinical and genetic characteristics of late-onset Huntington's disease 210
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 206
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 197
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience 194
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 193
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 191
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 179
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 177
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 175
Human fetal striatal transplantation in disease. First italian clinic trial at the University of Florence. Preliminare Report 174
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 174
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 174
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 162
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 162
Imaging perivenular distribution can differentiate MS from CNS vasculitis. 160
Leptomeningeal enhancement analysis in diagnostic clinical setting 159
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 152
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 147
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 144
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions 143
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 143
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume 138
Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg 123
Totale 5.664
Categoria #
all - tutte 15.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.597


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022172 0 15 11 10 0 10 7 21 9 9 28 52
2022/2023561 40 89 39 23 37 106 69 29 102 0 18 9
2023/2024284 11 32 31 18 22 27 13 45 4 32 30 19
2024/20251.797 62 169 113 282 384 264 24 238 77 32 68 84
2025/20262.009 257 218 131 180 248 75 264 85 140 113 59 239
2026/2027128 56 72 0 0 0 0 0 0 0 0 0 0
Totale 5.664